Natera PE Ratio 2014-2024 | NTRA
Current and historical p/e ratio for Natera (NTRA) from 2014 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Natera PE ratio as of February 21, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Natera PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-02-21 | 162.31 | 0.00 | |
| 2024-09-30 | 126.95 | $-1.76 | 0.00 |
| 2024-06-30 | 108.29 | $-2.45 | 0.00 |
| 2024-03-31 | 91.46 | $-3.12 | 0.00 |
| 2023-12-31 | 62.64 | $-3.79 | 0.00 |
| 2023-09-30 | 44.25 | $-4.52 | 0.00 |
| 2023-06-30 | 48.66 | $-4.82 | 0.00 |
| 2023-03-31 | 55.52 | $-5.35 | 0.00 |
| 2022-12-31 | 40.17 | $-5.57 | 0.00 |
| 2022-09-30 | 43.82 | $-5.68 | 0.00 |
| 2022-06-30 | 35.44 | $-6.06 | 0.00 |
| 2022-03-31 | 40.68 | $-5.88 | 0.00 |
| 2021-12-31 | 93.39 | $-5.17 | 0.00 |
| 2021-09-30 | 111.44 | $-4.58 | 0.00 |
| 2021-06-30 | 113.53 | $-3.67 | 0.00 |
| 2021-03-31 | 101.54 | $-3.10 | 0.00 |
| 2020-12-31 | 99.52 | $-2.81 | 0.00 |
| 2020-09-30 | 72.24 | $-2.38 | 0.00 |
| 2020-06-30 | 49.86 | $-1.99 | 0.00 |
| 2020-03-31 | 29.86 | $-1.72 | 0.00 |
| 2019-12-31 | 33.69 | $-1.81 | 0.00 |
| 2019-09-30 | 32.80 | $-1.86 | 0.00 |
| 2019-06-30 | 27.58 | $-2.02 | 0.00 |
| 2019-03-31 | 20.62 | $-2.16 | 0.00 |
| 2018-12-31 | 13.96 | $-2.23 | 0.00 |
| 2018-09-30 | 23.94 | $-2.59 | 0.00 |
| 2018-06-30 | 18.82 | $-2.61 | 0.00 |
| 2018-03-31 | 9.27 | $-2.51 | 0.00 |
| 2017-12-31 | 8.99 | $-2.60 | 0.00 |
| 2017-09-30 | 12.89 | $-2.45 | 0.00 |
| 2017-06-30 | 10.86 | $-2.44 | 0.00 |
| 2017-03-31 | 8.87 | $-2.38 | 0.00 |
| 2016-12-31 | 11.71 | $-1.85 | 0.00 |
| 2016-09-30 | 11.11 | $-1.60 | 0.00 |
| 2016-06-30 | 12.07 | $-1.49 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.205B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.197B | 27.76 |
| Elevance Health (ELV) | United States | $90.566B | 11.84 |
| CVS Health (CVS) | United States | $82.065B | 12.01 |
| Cencora (COR) | United States | $47.211B | 17.13 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| ICON (ICLR) | Ireland | $16.651B | 14.81 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Doximity (DOCS) | United States | $14.002B | 72.82 |
| Revvity (RVTY) | United States | $13.962B | 23.41 |
| Viatris (VTRS) | United States | $13.201B | 4.07 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Avantor (AVTR) | United States | $11.909B | 17.49 |
| CochLear (CHEOY) | Australia | $11.330B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.506B | 27.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.794B | 0.00 |
| HealthEquity (HQY) | United States | $9.682B | 48.57 |
| Sonic Healthcare (SKHHY) | Australia | $8.686B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.297B | 15.72 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.601B | 25.63 |
| Organon (OGN) | United States | $4.041B | 4.12 |
| Sotera Health (SHC) | United States | $3.829B | 20.49 |
| BrightSpring Health Services (BTSG) | United States | $3.552B | 75.56 |
| Surgery Partners (SGRY) | United States | $3.263B | 37.20 |
| Concentras Parent (CON) | United States | $2.981B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.791B | 338.60 |
| Alignment Healthcare (ALHC) | United States | $2.755B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.185B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.118B | 0.00 |
| Progyny (PGNY) | United States | $2.033B | 41.17 |
| PACS (PACS) | United States | $2.010B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.852B | 48.60 |
| Premier (PINC) | United States | $1.726B | 11.05 |
| Agilon Health (AGL) | United States | $1.492B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.480B | 12.40 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.254B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 7.81 |
| Establishment Labs Holdings (ESTA) | $0.981B | 0.00 | |
| Embecta (EMBC) | United States | $0.838B | 5.74 |
| Auna S.A (AUNA) | Luxembourg | $0.611B | 0.00 |
| DocGo (DCGO) | United States | $0.513B | 19.35 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| MultiPlan (MPLN) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.424B | 36.70 |
| Nutex Health (NUTX) | United States | $0.335B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.311B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.134B | 0.00 |
| So-Young (SY) | China | $0.114B | 19.40 |
| IceCure Medical (ICCM) | Israel | $0.083B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| ModivCare (MODV) | United States | $0.079B | 4.29 |
| Oncology Institute (TOI) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.62 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| KindlyMD (KDLY) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |